Tag: c_difficile
-
Antiviral Drug Fails to Improve Long COVID Symptoms in NIH Trial
A clinical trial found a common antiviral drug given for up to 25 days did not improve Long COVID symptoms. Other NIH Research Matters studies cover cystic fibrosis tRNA treatment and C. difficile in newborn mice.
HealthScience & TechnologyMedical ScienceGeneral PoliticsFederal GovernmentUSA Long COVIDantiviral drugclinical trialcystic fibrosistransfer RNAC. difficileNIH Research Matters